liu.seSearch for publications in DiVA
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Targeting the EGFR pathway for cancer therapy
University of Manitoba,Winnipeg, MB,R3E 0V9, Canada.
University of Manitoba,Winnipeg, MB,R3E 0V9, Canada.
University of Manitoba,Winnipeg, MB,R3E 0V9, Canada.
University of Manitoba,Winnipeg, MB,R3E 0V9, Canada.
Show others and affiliations
2006 (English)In: Current Medicinal Chemistry, ISSN 0929-8673, E-ISSN 1875-533X, Vol. 13, no 29, 3483-3492 p.Article in journal (Refereed) Published
Abstract [en]

Clinical studies have shown that HER-2/Neu is over-expressed in up to one-third of patients with a variety of cancers, including B-cell acute lymphoblastic leukemia (B-ALL), breast cancer and lung cancer, and that these patients are frequently resistant to conventional chemo-therapies. Additionally, in most patients with multiple myeloma, the malignant cells over-express a number of epidermal growth factor receptors (EGFR)s and their ligands, HB-EGF and amphiregulin, thus this growth-factor family may be an important aspect in the patho-biology of this disease. These and other, related findings have provided the rationale for the targeting of the components of the EGFR signaling pathways for cancer therapy. Below we discuss various aspects of EGFR-targeted therapies mainly in hematologic malignancies, lung cancer and breast cancer. Beside novel therapeutic approaches, we also discuss specific side effects associated with the therapeutic inhibition of components of the EGFR-pathways. Alongside small inhibitors, such as Lapatinib (Tykerb, GW572016), Gefitinib (Iressa, Z131839), and Erlotinib (Tarceva, OSI-774), a significant part of the review is also dedicated to therapeutic antibodies (e.g.: Trastuzumab / Herceptin, Pertuzumab / Omnitarg / rhuMab-2C4, Cetuximab / Erbitux / IMC-C225, Panitumumab / Abenix / ABX-EGF, and also ZD6474). In addition, we summarize, both current therapy development driven by antibody-based targeting of the EGFR-dependent signaling pathways, and furthermore, we provide a background on the history and the development of therapeutic antibodies.

Place, publisher, year, edition, pages
2006. Vol. 13, no 29, 3483-3492 p.
Keyword [en]
acute lymphoblastic-leukemia, acute myeloid-leukemia, cancer therapy, cell lung-cancer, cetuximab, egfr, erlotinib, gefitinib, growth-factor, lapatinib, metastatic breast-cancer, monoclonal-antibody, phase-ii trial, previously treated patients, randomized-trial, receptor tyrosine kinase, trastuzumab
National Category
Cancer and Oncology Biochemistry and Molecular Biology Medical Biotechnology (with a focus on Cell Biology (including Stem Cell Biology), Molecular Biology, Microbiology, Biochemistry or Biopharmacy)
Identifiers
URN: urn:nbn:se:liu:diva-86994DOI: 10.2174/092986706779026174ISI: 000242002600001OAI: oai:DiVA.org:liu-86994DiVA: diva2:584177
Available from: 2013-01-08 Created: 2013-01-08 Last updated: 2017-12-06

Open Access in DiVA

fulltext(81 kB)593 downloads
File information
File name FULLTEXT01.pdfFile size 81 kBChecksum SHA-512
2a69a00b66095810f9f21623eaa700ca4298f633c10e57a9f3db9eafd1ef7ae18b6b417b51accd9d1fd4c816ce08480e8a1aa62851b873f043210f2940eaa94e
Type fulltextMimetype application/pdf

Other links

Publisher's full text

Authority records BETA

Wiechec, EmiliaLos, Marek Jan

Search in DiVA

By author/editor
Wiechec, EmiliaLos, Marek Jan
In the same journal
Current Medicinal Chemistry
Cancer and OncologyBiochemistry and Molecular BiologyMedical Biotechnology (with a focus on Cell Biology (including Stem Cell Biology), Molecular Biology, Microbiology, Biochemistry or Biopharmacy)

Search outside of DiVA

GoogleGoogle Scholar
Total: 593 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
urn-nbn

Altmetric score

doi
urn-nbn
Total: 360 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf